浆细胞肿瘤相关血栓性事件的风险预防及临床管理  

Risk stratified thromboprophylaxis and management of thrombotic events in plasma cell neoplasms

作　　者：李群 孙春艳[1] Li Qun;Sun Chunyan(Department of Hematology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China)

机构地区：[1]华中科技大学同济医学院附属协和医院血液科,武汉430022

出　　处：《中华医学杂志》2025年第14期1041-1044,共4页National Medical Journal of China

基　　金：国家自然科学基金(82270214,82470205)。

摘　　要：肿瘤相关血栓性事件是浆细胞肿瘤最危险的并发症之一。血栓性事件的发生会干扰治疗计划的实施,损害患者的生活质量,严重时甚至威胁患者生命,给临床管理带来巨大挑战。因此,准确识别血栓相关风险因素并合理开展血栓预防具有重要意义。本文将针对浆细胞肿瘤相关血栓性事件的流行病学、风险评估和分层预防等问题进行探讨,旨在提高临床医师对这一常见并发症的认识,促进浆细胞肿瘤相关血栓性事件的规范化管理。Cancer-associated thrombosis is one of the most dangerous complications of plasma cell neoplasms.The occurrence of thrombotic events can disrupt treatment plans,compromise patients′quality of life,and even threaten their lives,which presents significant challenges in clinical management.Given the adverse impacts,the accurate identification of risk factors and the appropriate application of thromboprophylaxis are of great importance.This paper will discuss the epidemiology,risk assessment,and stratified thromboprophylaxis of thrombotic events in plasma cell neoplasms,with the aim of drawing clinicians′attention to this common complication and promoting the overall management of plasma cell tumor-related thrombotic diseases.

关 键 词：浆细胞肿瘤 血栓性事件 风险评估 分层预防 

分 类 号：R730.5[医药卫生—肿瘤]